5PSQ-012 Prescription of dabigatran in the elderly population

BACKGROUND: Atrial fibrillation (AF) is a common clinical problem, particularly in the elderly. Dabigatran is indicated for the prevention of stroke and systemic embolism, and the reduction of vascular mortality for patients with non-valvular atrial AF. The recommended daily dose of dabigatran is 15...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Eur J Hosp Pharm
Glavni autori: López-Sepúlveda, R, Soto, C Valencia, Rodríguez-Hermida, F Artime, Gómez, P Nieto, Herrera, S Guijarro, Lirola, MA García, García, E Espínola, Barrera, J Cabeza
Format: Artigo
Jezik:Inglês
Izdano: BMJ Group 2018
Teme:
Section 5: Patient safety and quality assurance
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535149/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.366
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items